SI-BONE, Inc. SIBN United States — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by SI-BONE, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about SI-BONE, Inc.'s united states — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SI-BONE, Inc.'s united states — revenue?
- SI-BONE, Inc. (SIBN) reported united states — revenue of $49.3M in Q1 2026.
- How has SI-BONE, Inc.'s united states — revenue changed year-over-year?
- SI-BONE, Inc.'s united states — revenue increased by 10.0% year-over-year, from $44.84M to $49.3M.
- What is the long-term trend for SI-BONE, Inc.'s united states — revenue?
- Over 4 years (2021 to 2025), SI-BONE, Inc.'s united states — revenue has grown at a 23.3% compound annual growth rate (CAGR), from $82.74M to $191.08M.
- What does united states — revenue mean?
- This metric represents the total gross sales generated from medical device products and surgical implant systems sold within the United States market. It serves as a primary indicator of the company's domestic market penetration, adoption of its proprietary sacroiliac joint and spinal fusion technologies, and overall commercial success in its largest geographic region. Tracking this revenue stream helps investors evaluate the scalability of the company's domestic sales force and the demand for its specialized orthopedic surgical solutions.